Orora Limited

ORA

Orora Ltd. engages in the manufacturing and distribution of fiber, glass and aluminum beverage cans. The company is headquartered in Hawthorn, Victoria and currently employs 7,533 full-time employees. The company went IPO on 2013-12-18. The firm is focused on designing and delivering products and services that enable its customers' brands to thrive. Its operations span Australasia, North America, Europe and the United Arab Emirates. Its operations include Global Beverage and Orora Packaging Solutions (OPS). Its global beverage business includes glass manufacturing, glass decoration, closures manufacturing and cans manufacturing. Its OPS business is a vertically integrated provider of sustainable manufacturing, distribution and visual solutions across North America. The firm specializes in custom packaging design, automation, supply chain optimization and visual solutions for a broad range of sectors. Its products include glass bottles, aluminum cans, closures and caps, and boxes and cartons. Its services include printing and signage, product sourcing, and automation and engineering.

Ordell Minerals Limited

ORD

Ordell Minerals Ltd is a AU-based company operating in Metals & Mining industry. The company is headquartered in Perth, Western Australia. The company went IPO on 2024-07-19. Ordell Minerals Limited is an Australia-based mineral exploration company. The firm has a prospective gold and lithium exploration portfolio, which includes three principal mineral assets: the Barimaia Joint Venture (JV) Project, the Goodia Project and the Fisher South Project located in the Yilgarn Craton of Western Australia (WA), Australia. The combined properties cover approximately 308 square kilometers (km2). The Barimaia JV Project comprises one mining lease, one exploration lease and 14 prospecting licenses in the Youanmi Terrane of the Yilgarn Craton near Mt Magnet. The Goodia Project is located within the eastern Goldfields region of WA and has the potential to host economic gold, nickel or lithium deposits. The project comprises one tenement E63/2313 and covers approximately 75km2. The Fisher South Project is located in the north-eastern Goldfields of WA, approximately 430km north of Kalgoorlie and comprises one tenement E53/2143, covering an area of 62 blocks (190km2).

Opthea Limited

OPT

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. The company is headquartered in Melbourne, Victoria. The firm is engaged in developing novel therapies to address the unmet need in the treatment of prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). Its lead product candidate, sozinibercept (OPT-302), is being evaluated in two pivotal Phase 3 clinical trials for use in combination with standard-of-care anti-VEGF-A monotherapies for the treatment of wet AMD and DME. The firm has also manufactured OPT-302 for use in Phase III clinical trials, conducts activities to support the commercialization of the product and expanded its management team in the United States to facilitate broader oversight and execution of its Phase III program. Its development activities are based on an intellectual property portfolio covering key targets (Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3).